22nd Century Group (NASDAQ:XXII – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, November 12th.
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.36) EPS for the quarter. The firm had revenue of $7.95 million for the quarter. 22nd Century Group had a negative net margin of 275.12% and a negative return on equity of 380.39%.
22nd Century Group Stock Up 2.9 %
22nd Century Group stock opened at $0.12 on Friday. 22nd Century Group has a 52-week low of $0.09 and a 52-week high of $6.69. The firm’s fifty day moving average is $0.20 and its 200 day moving average is $0.69. The company has a market cap of $5.63 million, a price-to-earnings ratio of 0.00 and a beta of 1.45.
Analyst Upgrades and Downgrades
View Our Latest Research Report on 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Further Reading
- Five stocks we like better than 22nd Century Group
- What is a Special Dividend?
- The Top 5 Performing S&P 500 Stocks YTD in 2024
- Bank Stocks – Best Bank Stocks to Invest In
- L3Harris: Positioned for Gains With Trump’s Defense Policies
- What Are Dividend Champions? How to Invest in the Champions
- Is First Solar’s Earnings Drop a Golden Buying Opportunity?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.